Milestone(MIST)

1.47 -0.02 -1.3423%

今开:1.49昨收:1.49
最高:1.5 最低:1.47
涨停价:0.0跌停价:0.0
总市值:7.8306261E7

Milestone的热门讨论

YuHsin06-18 15:28

您这Deadline有点随意、要不后边咱们还是改成Milestone吧[斜眼]查看全文

年度财报「修正」

Milestone(MIST)04-30 05:15

$Milestone(MIST)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-24-054157  Act: 34  Size: 612 KB 网页链接查看全文

当期报告

Milestone(MIST)05-13 19:35

$Milestone(MIST)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-060221  Act: 34  Size: 309 KB 网页链接查看全文

当期报告

Milestone(MIST)05-29 19:35

$Milestone(MIST)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-065806  Act: 34  Size: 267 KB 网页链接查看全文

当期报告

Milestone(MIST)07-16 04:05

$Milestone(MIST)$ 8-K Current report, items 1.01, 5.02, 5.08, 8.01, and 9.01 Accession Number: 0001104659-24-079854  Act: 34  Size: 374 KB 网页链接查看全文

其他

Milestone(MIST)07-16 04:45

$Milestone(MIST)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-079882  Act: 34  Size: 5 MB 网页链接查看全文

其他

Milestone(MIST)07-16 04:45

$Milestone(MIST)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-079881  Act: 34  Size: 1 MB 网页链接查看全文

首次持股声明

Milestone(MIST)07-18 04:25

$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019662  Size: 9 KB 网页链接查看全文

首次持股声明

Milestone(MIST)07-18 04:25

$Milestone(MIST)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-019666  Size: 9 KB 网页链接查看全文

持股变动声明

Milestone(MIST)07-18 04:25

$Milestone(MIST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019668  Size: 5 KB 网页链接查看全文

1 2

Milestone的最新讨论

YuHsin06-18 15:28

您这Deadline有点随意、要不后边咱们还是改成Milestone吧[斜眼]查看全文

Tiantian52004-22 17:11

回复@王隽: 要等很久的,如果把2030年前新增1200GW装机量作为一个milestone那么至少也要5年以上 道阻且长..//@王隽:回复@Tiantian520:大概率查看全文

SeekingBiotech2023-12-26 22:23

屋漏偏逢连夜雨
MIST Receives Refusal to File Letter from FDA for NDA for Etripamil in the Treatment of PSVT$Milestone制药(MIST)$ 也辛苦他们合作伙伴了查看全文

牛唐2023-05-09 22:49

医药板块速评(2022.05.08)
1、$Xencor(XNCR)$ Biotech卖铲人是否有反转契机?
2、$Milestone制药(MIST)$ 机构重磅押注,是否有配置机会?
3、 $诺和诺德(NVO)$ 、$IBM Corp(IBM)、$Carvana Co.(CVNA)、$Grab Holdings(GRAB)、$3M公司(MMM)等期权异动,后续走势如何看?查看全文

SeekingBiotech2023-03-29 00:01

$Milestone制药(MIST)$
MIST Announces $125 Million Strategic Financing .
1.25亿美金增发,心血管领域加强查看全文

牛唐2022-10-18 16:06

医药板块速评(2022.10.17)
本期内容提示:
1、大盘连日反弹,是否已经见底?$纳指100ETF-Invesco(QQQ)$
2、$Milestone制药(MIST)数据不错,股价暴跌,是否有抄底机会?
3、$Nikola(NKLA)$$追踪富时25中国股指数ETF-iShares(FXI)$ 、$爱彼迎(ABNB) 期权异动,后续走势如何看查看全文

产业链观察2022-10-17 18:06

药闻▶$Milestone制药(MIST)$ 宣布Etripamil鼻腔喷雾剂用于阵发性室上性心动过速患者的3期RAPID试验取得积极结果。
试验达到了主要终点,64.3%的自行服用依利帕米的患者在30分钟内转为窦性心律,而服用安慰剂的患者只有31.2%(HR=2.62,P<0.001)。
计划在2023年中期提交N...查看全文

牛唐2022-01-07 10:56

$生物医药控股(BHVN)$ 治疗偏头痛的药物NURTEC ODT卖的真好,四季度卖了1.4亿美元,去年全年卖了4.62亿。$Impel NeuroPharma(IMPL)$ $Milestone制药(MIST)$查看全文

一学就会2021-07-08 22:21

$Tilray(TLRY)$ Tilray marks milestone German weed harvest and launches medical prescriptions drive 不停的发利好,股价不停的跌,不解查看全文

1 2 3 4

Milestone的新闻

Milestone(MIST.US)盘前股价一度跌40% 新药申请遭FDA拒绝

智通财经APP获悉,总部位于加拿大的Milestone Pharmaceuticals(MIST.US)当地时间周二宣布,美国食品和药物管理局(FDA)拒绝接受其主要候选药物etripamil的新药上市申请(NDA)。此负面消息一出,Milestone股价在美股盘前一度下跌约40%。 ... 网页链接

美股异动 | Milestone Pharmaceuticals(MIST.US)盘前涨超35% 其心血管药物3期试验达主要终点

智通财经APP获悉,生物制药公司Milestone Pharmaceuticals(MIST.US)周一宣布,其主要药物etripamil在一项治疗阵发性室上性心动过速(PSVT)患者的3期临床试验中达到了主要终点。截至发稿,Milestone Pharmaceuticals盘前涨35.45%,报11.50... 网页链接

Milestone的公告

$Milestone制药(MIST)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-21-043131  Act: 34  Size: 56 KB 网页链接

$Milestone制药(MIST)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000947871-21-000181  Act: 34  Size: 44 KB 网页链接

$Milestone制药(MIST)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-21-003495  Act: 34  Size: 192 KB 网页链接

$Milestone制药(MIST)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000950142-21-000502  Act: 34  Size: 41 KB 网页链接

$Milestone制药(MIST)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000904454-21-000039  Act: 34  Size: 21 KB 网页链接

$Milestone制药(MIST)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-21-006400  Act: 34  Size: 119 KB 网页链接

$Milestone制药(MIST)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-003578  Act: 33  Size: 1 KB 网页链接

$Milestone制药(MIST)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-20-013774  Act: 34  Size: 5 MB 网页链接

$Milestone制药(MIST)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-20-020101  Size: 8 KB 网页链接

$Milestone制药(MIST)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-20-118163  Act: 34  Size: 437 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26